The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 11-Oct-2022 / 14:01 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
Norges Bank - Form 8.3 - Nektar Therapeutics, Inc PR Newswire London, October 11 ...
L FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1...
L FORM 8.3 OPENING DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 10-Oct-2022 / 14:21 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 47.18 | 47.18 | 47.18 | 4238 | 47.18 | DE |
4 | 0 | 0 | 47.18 | 47.18 | 47.18 | 12943 | 47.18 | DE |
12 | 0 | 0 | 47.18 | 47.18 | 47.18 | 6889 | 47.18 | DE |
26 | 0 | 0 | 47.18 | 47.18 | 47.18 | 6139 | 47.18 | DE |
52 | 0 | 0 | 47.18 | 47.18 | 47.18 | 8317 | 47.18 | DE |
156 | 0 | 0 | 47.18 | 47.18 | 47.18 | 6380 | 47.18 | DE |
260 | 0 | 0 | 47.18 | 47.18 | 47.18 | 3925 | 47.18 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約